Page 93 - CIBERESP2016-ENG

Most relevant scientific articles
• Rupérez M., González R., Mombo-Ngoma G., Kabanywanyi A.M., Sevene E., Ouedraogo S. et Al. Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study. PLoS Medicine. 2016;13(2).
• Rubio M., Bassat Q., Estivill X., Mayor A. Tying malaria and microRNAs: From the biology to future diagnostic perspectives. Malaria Journal. 2016;15(1).
• Domínguez A., Urbiztondo L., Bayas J.M., Borras E., Broner S., Campins M. Et Al. Serological survey of hepatitis B immunity in healthcare workers in Catalonia (Spain). Human Vaccines and Immunotherapeutics. 2016;1-5.
• Magallón-Tejada A., Machevo S., Cistero P., Lavstsen T., Aide P., Rubio M. et Al. Cytoadhesion to gC1qR through Plasmodium Falciparum Erythrocyte Membrane Protein 1 in Severe Malaria. PLoS Pathogens. 2016;12(11).
• O’callaghan-Gordo C., Casabonne D., Carrilho C., Ferro J., Lorenzoni C., Zaqueu C. et Al. Incidence of endemic burkitt lymphoma in three regions of Mozambique. American Journal of Tropical Medicine and Hygiene. 2016;95(6):1459-1462.
Highlights
Contextual information (2015 - 2016): Two new international projects have been launched: one operational
research project aimed at evaluating alternatives to increase the coverage of intermittent preventive treatment
of malaria in pregnancy (MIPPCOD Project) and a project aimed to improve technical capacity through
conducting three workshops reduction of maternal and neonatal mortality (Project Safe Mothers and Newborns:
a Leadership Workshop). The MIPPCOD (Malaria in Pregnancy Community Delivery) project (January 2015 to
April 2016) will determine - a number of elegible countries where it is feasible to evaluate the implementation of
intermittent preventive treatment (IPTp) delivery during pregnancy through community health workers (CHW), as
a complementary avenue to the current distribution through the antenatal care services in order to increase the
effective coverage of the IPTp, a highly cost-effective intervention that currently only 25% of pregnant women in
malaria endemic countries receives. In 2016, building on the Proyecto MIPPCOD that came to an end in April 2016,
a new proposal has been submitted to a UNiTAID funded call. The project TIPTOP aimed at evaluating delivery of
the intervention in the community in 4 countries (i.e. Democratic Republic of Congo, Madagascar, Mozambique
and Nigeria) has passed the first round of the two-stage evaluation process and final resolution is still pending. ItwillbephaseIIofpreviousMIPPCOD. Newresearchlineininequalitiesinmaternalandreproductivehealth.
The first output of which is a study of inequalities in health opportunities and outcomes in sub Saharan African
women of reproductive age. This piece of work has been conducted in collaboration with the Global Equity and
Poverty Practice of the World Bank. https://www.isglobal.org/en/web/guest/publication/-/asset_publisher/ ljGAMKTwu9m4/content/inequalities-in-women-s-and-girls-health-opportunities-and-outcomes-a-report-from- sub-saharan-africa-Moreover, in the field of training and capacity building in July 2016 we conducted the second
workshop on maternal and newborn mortality reduction in Boston (Project: Safe Mothers and Newborns: A
Leadership Workshop). http://www.safemothersandnewborns.org/overview. A review on the evidence on
Malaria in Pregnancy in the Americas was conducted. This was a review commissioned by the World Health Organization (WHO), through the Roll Back Malaria (RBM) – Malaria in Pregnancy Working Group, aimed to
understand the existing evidence available. The Demonstration project to implement an HPV vaccination
program to pre-adolescent girls through schools in Mozambique (HPVvax Project). The Barcelona
Institute for Global Health (ISGlobal), the Manhiça Health Research Center (CISM), and the Fundaçao para o Desenvolvimento da Comunidade (FDC) in Mozambique have been actively involved and provided support to the
Ministry of Health of Mozambique in undertaking the first pilot Demonstration project for HPV vaccination in the
country. The study of the ZIKV infection in pregnant women returning from ZIKV affected areas and the impact of
maternal and infant health. This study started in January 2016 at the Hospital Clinic of Barcelona (HCB), a tertiary
referral hospital with the aim to investigate the clinical features of the ZIKV infection in pregnancy, the impact
of ZIKV on maternal and foetal health, and the understanding of the ZIKV in uterus. Also during 2016 the results
obtained in more than 50 autopsies conducted to women who died during pregnancy, delivery or postpartum in Mozambique between 2014 and 2015 have been analyzed. ESP
Research groups 93